S&CO Inc’s Agios Pharmaceuticals AGIO Stock Holding History

S&CO Inc’s Portfolio AGIO Stock Details AGIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-6,000	Closed	-$276K	–	194
2021 Q3	$276K	Hold	6,000	–	–	0.02%	176
2021 Q2	$330K	Hold	6,000	–	–	0.03%	164
2021 Q1	$309K	Buy	+6,000	New	+$297K	0.03%	165
2019 Q2	–	Sell	-3,400	Closed	-$229K	–	187
2019 Q1	$229K	Buy	+3,400	New	+$198K	0.03%	180
2018 Q4	–	Sell	-3,400	Closed	-$262K	–	179
2018 Q3	$262K	Hold	3,400	–	–	0.03%	172
2018 Q2	$286K	Hold	3,400	–	–	0.03%	182
2018 Q1	$278K	Buy	+3,400	New	+$263K	0.04%	182
2017 Q4	–	Sell	-3,400	Closed	-$227K	–	186
2017 Q3	$227K	Buy	+3,400	New	+$204K	0.03%	175
2016 Q1	–	Sell	-3,400	Closed	-$221K	–	141
2015 Q4	$221K	Hold	3,400	–	–	0.04%	133
2015 Q3	$240K	Hold	3,400	–	–	0.04%	133
2015 Q2	$378K	Hold	3,400	–	–	0.06%	116
2015 Q1	$321K	Sell	3,400 -300	-8%	-$33.6K	0.05%	121
2014 Q4	$415K	Sell	3,700 -1,300	-26%	-$116K	0.06%	112
2014 Q3	$307K	Hold	5,000	–	–	0.05%	116
2014 Q2	$229K	Buy	+5,000	New	+$204K	0.03%	133

Other funds holding AGIO

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

S&CO Inc's AGIO Position: Q4 2021 in Review

S&CO Inc sold out of Agios Pharmaceuticals (AGIO) in Q4 2021, closing a stake of 6,000 shares — an estimated $276K sold.

S&CO Inc first reported a position in AGIO in Q2 2014 and held it in 15 quarters. The position peaked at $415K in Q4 2014. 161 funds tracked by Wall St. Rank hold AGIO as of Q4 2021.

S&CO Inc reported no remaining Agios Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
S&CO Inc sold 6,000 Agios Pharmaceuticals shares in Q4 2021, an estimated $276K.
S&CO Inc first reported a position in Agios Pharmaceuticals in Q2 2014 and held it in 15 quarters.
S&CO Inc's Agios Pharmaceuticals position peaked at $415K in Q4 2014.
161 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q4 2021.

Based on S&CO Inc's 13F filing for Q4 2021, filed 8 Feb 2022.